Starpharma Holdings Limited
SPHRF
$0.084
$0.00020.24%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.74M | 4.57M | 6.38M | 6.68M | 7.00M |
| Total Other Revenue | -- | -- | -- | 10.40K | 21.00K |
| Total Revenue | 2.74M | 4.57M | 6.38M | 6.69M | 7.02M |
| Cost of Revenue | 6.53M | 6.79M | 7.01M | 7.36M | 7.77M |
| Gross Profit | -3.79M | -2.22M | -624.50K | -672.30K | -750.20K |
| SG&A Expenses | 4.47M | 4.62M | 4.75M | 4.81M | 4.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.00M | 11.41M | 11.75M | 12.17M | 12.67M |
| Operating Income | -8.26M | -6.84M | -5.37M | -5.48M | -5.65M |
| Income Before Tax | -8.26M | -6.84M | -5.37M | -5.48M | -5.65M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.26 | -6.84 | -5.37 | -5.48 | -5.65 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.26M | -6.84M | -5.37M | -5.48M | -5.65M |
| EBIT | -8.26M | -6.84M | -5.37M | -5.48M | -5.65M |
| EBITDA | -8.07M | -6.64M | -5.16M | -5.26M | -5.42M |
| EPS Basic | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 1.66B | 1.65B | 1.65B | 1.64B | 1.64B |
| Average Diluted Shares Outstanding | 1.66B | 1.65B | 1.65B | 1.64B | 1.64B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |